Tetsu Tomonari

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 8

Top Topics

Metastatic Colorectal Cancer

Radiation Therapy

Top Venues

Hepatology research : the official journal of the Japan Society of Hepatology

JGH open : an open access journal of gastroenterology and hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Tetsu Tomonari, Joji Tani, Chikara Ogawa, Akihiro Deguchi, Tomonori Senoh, Akio Moriya, Hiroshi Shibata, Hiroshi Fukuno, Hironori Tanaka, Takahiro Tanaka, Tatsuya Taniguchi, Masahiro Sogabe, Yutaka Kawano, Akihiro Morishita, Koichi Takaguchi, Hiroshi Miyamoto, Yasushi Sato, Tsutomu Masaki, Tetsuji Takayama
Multicenter retrospective study of initial treatment outcome and feasibility of initiating dose reduction of cabozantinib in unresectable hepatocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology (2022)
Tetsu Tomonari, Joji Tani, Yasushi Sato, Hironori Tanaka, Takahiro Tanaka, Tatsuya Taniguchi, Morishita Asahiro, Koichi Okamoto, Masahiro Sogabe, Hiroshi Miyamoto, Naoki Muguruma, Tsutomu Masaki, Tetsuji Takayama
Initial therapeutic results of atezolizumab plus bevacizumab for unresectable advanced hepatocellular carcinoma and the importance of hepatic functional reserve. Cancer medicine (2022)
Hironori Ochi, Joji Tani, Tetsu Tomonari, Tatsuya Taniguchi, Yohei Koizumi, Akira Hirose, Chikara Ogawa, Atsushi Hiraoka, Akihiro Morishita, Akio Moriya, Masashi Hirooka, Akihiro Deguchi, null Symple Study Group
Sequential therapy including regorafenib for unresectable hepatocellular carcinoma: Effect of early relative changes in hepatic functional reserve after regorafenib administration on prognosis. Hepatology research : the official journal of the Japan Society of Hepatology 51 (12) (2021)
Tetsu Tomonari, Yasushi Sato, Joji Tani, Akira Hirose, Chikara Ogawa, Akihiro Morishita, Hironori Tanaka, Takahiro Tanaka, Tatsuya Taniguchi, Koichi Okamoto, Masahiro Sogabe, Hiroshi Miyamoto, Naoki Muguruma, Kazushige Uchida, Tsutomu Masaki, Tetsuji Takayama
Comparison of therapeutic outcomes of sorafenib and lenvatinib as primary treatments for hepatocellular carcinoma with a focus on molecular-targeted agent sequential therapy: A propensity score-matched analysis. Hepatology research : the official journal of the Japan Society of Hepatology 51 (4) (2021)
Tetsu Tomonari, Yasushi Sato, Hironori Tanaka, Takeshi Mitsuhashi, Akihiro Hirao, Takahiro Tanaka, Tatsuya Taniguchi, Koichi Okamoto, Masahiro Sogabe, Hiroshi Miyamoto, Naoki Muguruma, Tetsuji Takayama
Therapeutic efficacy of lenvatinib in nonviral unresectable hepatocellular carcinoma. JGH open : an open access journal of gastroenterology and hepatology 5 (11) (2021)
Tetsu Tomonari, Yasushi Sato, Hironori Tanaka, Takahiro Tanaka, Tatsuya Taniguchi, Masahiro Sogabe, Koichi Okamoto, Hiroshi Miyamoto, Naoki Muguruma, Yu Saito, Satoru Imura, Yoshimi Bando, Mitsuo Shimada, Tetsuji Takayama
Conversion therapy for unresectable hepatocellular carcinoma after lenvatinib: Three case reports. Medicine 99 (42) (2020)
Tetsu Tomonari, Yasushi Sato, Hironori Tanaka, Takahiro Tanaka, Tatsuya Taniguchi, Msasahiro Sogabe, Koichi Okamoto, Hiroshi Miyamoto, Naoki Muguruma, Tetsuji Takayama
Sorafenib as second-line treatment option after failure of lenvatinib in patients with unresectable hepatocellular carcinoma. JGH open : an open access journal of gastroenterology and hepatology 4 (6) (2020)
Masahiro Sogabe, Toshiya Okahisa, Takeshi Kurihara, Masanori Takehara, Kaizo Kagemoto, Jun Okazaki, Yoshifumi Kida, Akihiro Hirao, Hironori Tanaka, Tetsu Tomonari, Tatsuya Taniguchi, Koichi Okamoto, Masahiko Nakasono, Tetsuji Takayama
Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome. PloS one 15 (8) (2020)